Hospice fraud in California has emerged as a significant issue drawing attention from both federal and state authorities, as well as becoming a point of political contention. The state has been identified as a focal point for schemes involving unauthorized enrollment of Medicare recipients into hospice care, including cases where patient identities were stolen and sham providers submitted fraudulent claims to Medicare.
Investigations have revealed various fraudulent tactics, such as signing up individuals without their knowledge, offering kickbacks for enrollment of patients who do not meet hospice eligibility, and creating fictitious employee rosters. One notable example involved individuals being promised payments to enroll in hospice care they did not require, while in another case, stolen personal data was used to bill Medicare $267 million for nonexistent services.
Federal officials, including Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, have intensified their scrutiny of California's hospice system. A recent House committee hearing focusing on Medicare fraud highlighted the problem, with some lawmakers, primarily Republicans, characterizing California and other Democratic-led states as epicenters of fraud that have enabled millions in fraudulent Medicare claims. Representative Jason Smith, chairman of the House Ways and Means Committee, criticized the state’s oversight, stating it had effectively “opened the door” to widespread theft.
At the same time, California state officials and Democratic leaders have pushed back against accusations, citing ongoing efforts to curb abuse. Governor Gavin Newsom, who signed a moratorium on new hospice licenses in 2021, has highlighted state actions, including revoking hundreds of hospice licenses and initiating numerous criminal cases. State regulators are also developing more stringent licensing regulations intended to enforce higher standards for hospice ownership, staffing, and employee background checks.
A 2022 state audit, prompted by investigative reporting, exposed regulatory weaknesses that contributed to the proliferation of hospice providers, particularly in areas such as Los Angeles, where the concentration of licensed hospices far exceeded that in other states. The audit found California’s licensing process lacked requirements present in states like Florida and New York, such as demonstrating regional need or conducting thorough background checks. These shortcomings, the audit suggested, created vulnerabilities exploited by fraudulent operators.
Advocates for Medicare beneficiaries in California have welcomed increased focus on the issue, emphasizing the risks posed to vulnerable patients and the importance of safeguarding taxpayer dollars. Some have criticized the political framing of the problem, with Newsom’s office labeling the administration’s rhetoric as a distraction that overlooks fraud occurring in conservative-led states.
Recent federal initiatives include making it easier for individuals mistakenly enrolled in hospice to disenroll and restoring access to their Medicare benefits, along with notifications to beneficiaries informing them of hospice enrollments. Despite these measures, California's efforts to finalize tighter regulations faced delays, with new requirements now expected to take effect next year.
Lawmakers from both parties have expressed the potential for collaboration between state and federal authorities to address the fraud, recognizing that the issue affects all levels of government. The continuing investigations and policy developments reflect heightened urgency to protect vulnerable patients and curb the financial losses linked to hospice fraud in California.